mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.8 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.8 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |